Cambridge, MA, United States of America

Miguel Alonso Alonso

This inventor holds 1 USPTO granted patent. Top assignee: Bioverativ USA Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miguel Alonso Alonso. Retrieved from https://idiyas.com/inventor/miguel-alonso-alonso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miguel Alonso Alonso: Innovator in Complement-Mediated Disease Treatment

Introduction

Miguel Alonso Alonso is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of complement-mediated diseases. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Miguel Alonso Alonso holds a patent titled "Methods for Treating Complement-Mediated Diseases." This patent represents a significant advancement in therapeutic approaches, showcasing his commitment to improving patient outcomes.

Career Highlights

Currently, Miguel Alonso Alonso is employed at Bioverativ USA Inc. His role at the company allows him to leverage his expertise in developing innovative solutions for complex medical challenges. His work is characterized by a strong focus on research and development, contributing to the advancement of medical science.

Collaborations

Miguel has collaborated with esteemed colleagues, including Rene Belder and Timothy Wing Yau Chow. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

In summary, Miguel Alonso Alonso is a dedicated inventor whose work in treating complement-mediated diseases has the potential to transform medical practices. His contributions to Bioverativ USA Inc. and his collaborations with other professionals highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…